CHWY Q4 Deep Dive: Margin Expansion and Strategic Investments Drive Positive Outlook

E-commerce pet food and supplies retailer Chewy (NYSE:CHWY) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.7% year on year to $3.36 billion. Its non-GAAP profit of $0.43 per share was in line with analysts’ consensus estimates.

Is now the time to buy CHWY? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Chewy’s fourth quarter results were met positively by the market, reflecting steady execution in a challenging environment for pet retail. Management credited robust recurring revenue from its Autoship program, which now accounts for over 80% of net sales, and emphasized gains in operational efficiency. CEO Sumit Singh highlighted a continued focus on premium product mix and disciplined expense management, stating, “We are delivering share gains, expanding margins through structural efficiencies and generating growing free cash flow.” The company also noted that customer net additions remained healthy, driven by new initiatives in health and private brands. Notably, net sales for Q4 grew 8.1% year over year on a comparable 52-week basis.

Looking ahead, Chewy’s management expects growth to be fueled by further expansion of its health and wellness offerings, ongoing advances in AI-driven efficiency, and a new unified private brand platform. Singh pointed to a multi-year margin expansion strategy, with particular emphasis on cost leverage from fulfillment centers and AI tools expected to deliver tens of millions in savings. While the outlook is based on a stable pet industry environment, CFO Chris Deppe noted that “improvements in operating leverage and a balanced approach to customer growth and spend per customer” are central to meeting 2026 profitability targets.

Key Insights from Management’s Remarks

Management attributed the quarter’s performance to recurring revenue strength, margin improvements from operational initiatives, and the early benefits of new strategic investments in health and AI.

• Autoship growth remains strong: The recurring revenue model, with over 80% of net sales on Autoship, provided stability and high customer retention, particularly as Autoship customer sales outpaced overall top line growth.
• Private brand expansion: The launch of Chewy Made—a new unified owned brand platform—aims to increase penetration in dog and cat consumables, broaden price points, and consolidate existing brands, targeting both margin improvement and expanded reach.
• Veterinary services scale: Chewy Vet Care (CVC) opened 10 new practices in 2025, now with 18 locations, and is cited as a key driver of higher spend per customer (NSPAC) and deeper customer engagement, supporting the company’s ecosystem strategy.
• AI-driven operational efficiencies: The company is deploying AI across customer service, fulfillment, and marketing operations, with early results showing reduced handle times and improved productivity. Management expects these efficiencies to improve cost structure and contribute tens of millions in savings in 2026.
• SmartEquine acquisition integration: The recently acquired SmartEquine business is being stabilized in 2026, with management targeting future growth in the pet health supplement category. While not expected to meaningfully impact near-term profits, it complements Chewy’s broader health strategy.

Drivers of Future Performance

Chewy’s outlook for the coming year is shaped by steady industry demand, continued margin expansion, and a disciplined focus on customer growth and operational leverage.

• Stable industry environment: Management expects low single-digit growth in the pet category, with no rebound in household formation or price inflation assumed. The strategy is built on gaining market share through active customer growth and spend per customer, not industry tailwinds.
• Margin expansion from efficiency gains: The ramp-up of the Houston Fulfillment Center and the scaling of AI-driven tools are expected to structurally lower costs, with management guiding for 100 basis points of adjusted EBITDA margin expansion, primarily from operating leverage and mix improvements.
• Private brands and health mix: The rollout of Chewy Made and continued growth in health and veterinary services are positioned to drive higher-margin sales, with management targeting mid-teens private brand penetration and ongoing growth in high-margin health verticals.

Catalysts in Upcoming Quarters

In the next few quarters, our analyst team will watch (1) the ramp and customer adoption of the Chewy Made private brand platform, (2) the measurable impact of AI-driven cost savings on operating margins, and (3) the continued growth and profitability of Chewy Vet Care. Progress in integrating the SmartEquine acquisition and expansion in health services will also be important signposts.

Chewy currently trades at $19.92, down from $20.42 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).

High Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.